Treatment of Children With ADHD Who do Not Fully Respond to Stimulants (TREAT)
Developing More Efficacious Treatments for Children With ADHD Who Are Partial or Non-responders to Stimulants
Sponsor: Bristol-Myers Squibb
Terminated
Recruitment Rate too slow
Other terminated trials from Bristol-Myers Squibb
Other Attention Deficit Hyperactivity Disorder trials with similar outcome
A PHASE2 clinical study on Attention Deficit Hyperactivity Disorder, this trial is terminated or withdrawn. The trial is conducted by Bristol-Myers Squibb and has accumulated 9 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 4 earlier versions
-
Jul 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
Jun 2018 — Jul 2020 [monthly]
Terminated PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Jul 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Bristol-Myers Squibb
- National Institute of Mental Health (NIMH)
- New York State Psychiatric Institute
- Otsuka Pharmaceutical Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .